This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Immatics US, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Agathe Bourgogne: Innovating T Cell Manufacturing in Houston, TX
Introduction
Agathe Bourgogne is an accomplished inventor located in Houston, Texas. She has made significant contributions in the field of immunotherapy, particularly through her innovative work on methods for manufacturing T cells. With one patent to her name, Bourgogne is making strides in the world of biotechnology.
Latest Patents
Agathe Bourgogne holds a patent for "Methods for manufacturing T cells." This patent discloses various techniques related to the production of T cells for adoptive immunotherapy. It covers methods for genetically transducing T cells, utilizing T cell populations, and provides comprehensive protocols for thawing frozen peripheral blood mononuclear cells (PBMC). The innovative approach includes activating T cells in cultured PBMC using anti-CD3 and anti-CD28 antibodies, followed by transduction with a viral vector, expanding the transduced T cells. This groundbreaking work aims to enhance the efficacy of immunotherapy treatments.
Career Highlights
Bourgogne's career is marked by her pivotal role at Immatics US, Inc., a company that focuses on the development of T cell-based immunotherapies. Her expertise in T cell manufacturing has positioned her at the forefront of research and development in this field. Through her dedication and innovative spirit, Agathe is contributing to advancing therapeutic options for patients with cancer and other immune-related conditions.
Collaborations
Throughout her career, Agathe Bourgogne has collaborated with other talented professionals, including Mamta Kalra and Zoe Coughlin. These collaborations enhance the research environment, fostering innovation and the exchange of ideas that are critical for breakthroughs in biotechnology.
Conclusion
Agathe Bourgogne is a notable inventor whose work in manufacturing T cells is reshaping the landscape of adoptive immunotherapy. With her patent and collaborations at Immatics US, Inc., she exemplifies the vital role of innovation in the fight against diseases. As research in this field continues to evolve, Bourgogne's contributions will undoubtedly play a crucial part in improving patient outcomes and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile